Article
Hypermethylation of TMEM240 Involved in Expression Deficiency Predicts Poor Hormone Therapy Response and Disease Progression in Breast Cancer
2021-11-10
Abstract excerpt
<h4>Background: </h4> Approximately 25% of patients with early-stage breast cancer experience cancer progression throughout the disease course. Alterations in TMEM240 in breast cancer were identified and investigated to monitor treatment response and disease progression. <h4>Methods: </h4>: Circulating methylated TMEM240 in the plasma of breast cancer patients was used to monitor treatment response and relapse eve...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 39da7ac5-cd50-5a41-b17b-aec007f2953e
- DOI
- 10.21203/rs.3.rs-1021973/v1
